ClinicalTrials.Veeva

Menu

Assessment of Long-term Impact Post COVID-19 for Patients and Health Care Professionals of the European Hospital (ALCOVID)

H

Hôpital Européen Marseille

Status

Active, not recruiting

Conditions

Covid19

Treatments

Diagnostic Test: Diagnostic Test: serology test for COVID-19

Study type

Observational

Funder types

Other

Identifiers

NCT04525911
2020- A01647-32

Details and patient eligibility

About

The purpose of the study is to Assess of Long-term impact post COVID for patients and health care professionals.The patients and medical staff will be followed for 2 years in order to provide clinical and paraclinical data not yet published in the literature.

Enrollment

214 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Aged ≥ 18 years,
  • Symptomatic COVID-19 infection confirmed (by RT-PCR or ELISA serology) or probable (CT criteria),
  • Having given free and informed written consent,
  • Being affiliated with or benefiting from a social security scheme.
  • Patients / caregivers may be included in several ancillary studies at the same time.

Exclusion criteria

-Subject to a measure for the protection of justice

Trial design

214 participants in 1 patient group

Symptomatic COVID-19 infection confirmed or probable
Description:
Patients and medical staff having symptomatic COVID-19 infection confirmed (by RT-PCR or ELISA serology) or probable (CT criteria)
Treatment:
Diagnostic Test: Diagnostic Test: serology test for COVID-19

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems